Global Rabies Vaccine for Humans Market Study 2016-2026, by Segment (Preventative Vaccine, Emergency Rabies Vaccine), by Market (Pre-exposure prophylaxis, Post-exposure prophylaxis), by Company (Novartis, Sanofi, … …)
SKU ID :99ST-14631817 | Published Date: 29-Oct-2019 | No. of pages: 56Description
Summary
The global Rabies Vaccine for Humans market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Preventative Vaccine
Emergency Rabies Vaccine
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Pre-exposure prophylaxis
Post-exposure prophylaxis
Novartis
Sanofi
GlaxoSmithKline
Merck
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Rabies Vaccine for Humans market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Preventative Vaccine
Emergency Rabies Vaccine
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Pre-exposure prophylaxis
Post-exposure prophylaxis
Company Coverage (Sales data, Main Products & Services etc.):
Novartis
Sanofi
GlaxoSmithKline
Merck
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now